Oracle Corp SEC Filings

Douglas A. Kehring, Executive Vice President and Principal Financial Officer of Oracle Corp (ORCL), filed an initial Form 3 reporting his beneficial ownership. He directly owns 68,592 shares of Oracle common stock and indirectly holds 2,157.514 units through the company 401(k) plan. He also holds unvested restricted stock units totaling 212,... (213,101) RSUs from three prior grants that convert one-for-one to common shares upon settlement and vest in annual installments.

Mark Hura filed an initial Form 3 reporting his beneficial ownership in Oracle Corporation (ORCL) following his appointment as President, Global Field Operations. The filing reports 254,077 shares of Oracle common stock held directly and 162,959 unvested restricted stock units (RSUs) that each convert to one share at settlement. The RSUs come from three prior grants: 190,868 RSUs granted 09/20/2022 (vesting in four equal annual installments), 114,126 RSUs granted 09/15/2023 (four annual installments), and 77,571 RSUs granted 09/19/2024 (four annual installments).

The statement was signed by an attorney-in-fact on behalf of Mr. Hura on 10/01/2025 and reflects holdings as of the 09/22/2025 event date. All reported RSUs are unvested and scheduled to vest in equal annual tranches starting on each grant's first anniversary, indicating future potential share settlement rather than current voting shares.

Naomi O. Seligman, a director of Oracle Corporation (ORCL), reported transactions in Oracle common stock on 09/26/2025. The filing shows a sale of 2,222 shares at $288.91 (transaction code S), followed the same day by a gift of 1,406 shares (transaction code G) with no cash consideration. After those transactions the reporting person is shown as directly owning 29,225 shares following the sale and 27,819 shares following the gift. The filing discloses 6,000 shares held indirectly by spouse and 14,414 shares held indirectly by a trust. An administrative correction notes 10 shares were previously overreported. The Form 4 is signed by attorney-in-fact Aimee Weast on behalf of Ms. Seligman.

Michael D. Sicilia, listed as Chief Executive Officer, reported the acquisition of a large stock option award in Oracle Corporation (ORCL). The Form 4 shows a derivative transaction dated 09/24/2025 in which 1,037,412 stock options were acquired with an exercise (conversion) price of $308.46. The filing reports the options as directly beneficially owned following the transaction.

The options have an exercisable/expiration date entry of 09/24/2035 and the form states that 25% of the shares subject to the option vest annually on each anniversary of the grant date. The form is signed by an attorney-in-fact, Aimee Weast, under power of attorney dated 06/12/2025, with signature dated 09/26/2025.

Clayton M. Magouyrk, listed as Chief Executive Officer, reported a Section 16 Form 4 for Oracle Corporation (ORCL) reflecting a grant of stock options. The filing shows a derivative security described as a Stock Option with an exercise price of $308.46, dated 09/24/2025, for 2,593,530 option shares. The filing notes 25% of the shares subject to the option vest annually on each anniversary of the grant date. The reported options are held directly. The Form 4 was signed under power of attorney on 09/26/2025.

Oracle's definitive proxy discloses governance, succession and executive compensation actions for fiscal 2025. The company completed a planned CEO succession in September 2025: Safra Catz retired as CEO and PFO and became Executive Vice Chair, and Mr. Magouyrk and Mr. Sicilia were appointed as co-CEOs. Douglas Kehring was appointed Executive Vice President, Principal Financial Officer. The proxy calls for election of 13 directors, an advisory vote on named executive officer compensation, and ratification of Ernst & Young LLP as auditor for fiscal 2026.

The Compensation Committee elected not to pay annual cash bonuses for fiscal 2025 to preserve cash for strategic AI and growth priorities, and reduced performance-based bonuses to $0 (with one forfeiture noted). Long-term incentive outcomes included partial vesting of eight-year performance-based stock options. Key reported metrics include GAAP operating margin of 31% and GAAP earnings per share of $4.34. The proxy was first made available to stockholders on or about September 26, 2025.

Oracle Corporation reported documentation and terms for a proposed debt offering. The company references an existing S-3 registration statement filed March 15, 2024, and a preliminary and final prospectus supplement both dated September 24, 2025, indicating a securities offering process is underway.

Forms are provided for six note series: 4.450% due 2030, 4.800% due 2032, 5.200% due 2035, 5.875% due 2045, 5.950% due 2055, and 6.100% due 2065. An Officers' Certificate dated September 26, 2025 sets forth the notes' terms, and legal opinion and consent from Freshfields US LLP are included, along with an interactive cover page Inline XBRL file. The filing is administrative documentation of the planned note issuance rather than operating results.

ORCL Form 144 filing shows a proposed sale of 2,222 common shares through Fidelity Brokerage Services on 09/26/2025 with an aggregate market value of $641,958.24. The shares were acquired on 05/31/2022 by restricted stock vesting and were received as compensation. The filing also discloses that Naomi Seligman sold 3,303 common shares on 07/16/2025 for $770,656.29. The issuer's outstanding shares are listed as 2,841,714,000, indicating these transactions are small relative to total shares outstanding.